These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1750106)

  • 1. Hepatic dysfunction in undernourished patients receiving isoniazid and rifampicin.
    Krishnaswamy K; Prasad CE; Murthy KJ
    Trop Geogr Med; 1991; 43(1-2):156-60. PubMed ID: 1750106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatotoxicity of isoniazid and rifampin in children.
    Rugmini PS; Mehta S
    Indian Pediatr; 1984 Feb; 21(2):119-26. PubMed ID: 6469294
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid-rifampicin-induced submassive hepatic necrosis.
    Kasantikul V
    J Med Assoc Thai; 1989 Jan; 72(1):56-8. PubMed ID: 2723568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].
    Musch E; Eichelbaum M; Wang JK; von Sassen W; Castro-Parra M; Dengler HJ
    Klin Wochenschr; 1982 May; 60(10):513-9. PubMed ID: 7098379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
    Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB
    Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
    Skakun NP; Tabachuk OE
    Probl Tuberk; 1991; (10):77-9. PubMed ID: 1788241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
    Kozma D; Mihalik P; Schaff Z; Lapis K
    Probl Tuberk; 1982 Jul; (7):68-72. PubMed ID: 7134213
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoniazid hepatotoxicity after orthotopic liver transplantation.
    Schluger LK; Sheiner PA; Jonas M; Guarrera JV; Fiel IM; Meyers B; Berk PD
    Mt Sinai J Med; 1996; 63(5-6):364-9. PubMed ID: 8898542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant hepatitis during treatment with rifampicin, pyrazinamid and ethambutol.
    van Aalderen WM; Knoester H; Knol K
    Eur J Pediatr; 1987 May; 146(3):290-1. PubMed ID: 3595648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity caused by the combined action of isoniazid and rifampicin.
    Askgaard DS; Wilcke T; Døssing M
    Thorax; 1995 Feb; 50(2):213-4. PubMed ID: 7701468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Halothane and antituberculous drugs--a hepatotoxic combination? (author's transl)].
    Schmidt-Wilcke HA; Wolfert W; Grundmann E
    Z Gastroenterol; 1977 Aug; 15(8):504-11. PubMed ID: 906600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
    Burke M; Logan J
    Ir Med J; 1979 Oct; 72(10):430-4. PubMed ID: 500344
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hydrazide-rifampicin: hepatotoxicity in children].
    Uriz Urzainqui S; Masvidal Aliberch RM; Sabriá Pau J; Bofill Bernaldo AM
    An Esp Pediatr; 1981 Oct; 15(4):401-3. PubMed ID: 7337305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.